Table 5 Statements reflecting what the public thinks is important to consider when using surplus embryos for drug development
Statements | Median (IQR) | Ranked as most important (n) |
|---|---|---|
It is important to access new, effective treatments against diseases that do not have any | 1 (2) | 255 |
It is important to try to reduce the risks for severe side-effects associated with medical treatments | 2 (2) | 23 |
It is important with transparency and scrutiny if medical companies are involved in developing treatment with embryonic stem cells | 4 (2) | 32 |
It is important that legislators consider the different values in society when deciding on the use of embryos for medical treatment | 5 (3) | 45 |
Patients should be informed on how their treatment has been developed before deciding whether they accept treatment or not | 5 (4) | 17 |
If we allow embryos to be used for medical treatment, there is a risk that we, in the future, will allow unwanted usage | 6 (3) | 14 |
For moral reasons, it is preferable to use induced pluripotent stem cells instead of embryonic stem cells | 6 (3) | 25 |
Couples donating embryos should not be compensated economically for their donation | 6 (4) | 25 |